The “Entrepreneurial State” and the Leveraging of Life in the Field of Regenerative Medicine

Governments are attempting to create a ‘health and wealth’-generating Regenerative Medicine industry in a manner that aligns with the Entrepreneurial State by supporting innovation -facilitating initiatives. This chapter explores such initiatives in the UK and the values invoked within them. The chapter argues that the power of the Entrepreneurial State in reconfiguring the bioeconomy derives from its capacity to appeal to diverse values, and consequently, mobilize and orientate a range of actors (industry , scientists, clinicians and patients ) into a common project aimed at generating ‘health and wealth’. The chapter reflects on the State’s role in attempting to serve as a broker between public and private good, and in doing so it also highlight some of the tensions and countervailing processes at play within the new health bioeconomy .

[1]  Georgina Born,et al.  Logics of interdisciplinarity , 2008 .

[2]  Claes-Fredrik Helgesson,et al.  Value Practices in the Life Sciences and Medicine , 2015 .

[3]  C. Mason,et al.  A brief definition of regenerative medicine. , 2008, Regenerative medicine.

[4]  D. Sipp Conditional approval: Japan lowers the bar for regenerative medicine products. , 2015, Cell stem cell.

[5]  Nafees N. Malik Reimbursement and adoption of advanced therapies: the 5-C framework. , 2014, Regenerative medicine.

[6]  C. Parish Stem the tide. , 2002, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[7]  Christine Hauskeller,et al.  The clinician-scientist: professional dynamics in clinical stem cell research. , 2012, Sociology of health & illness.

[8]  Patrik Aspers,et al.  Theory, Reality, and Performativity in Markets , 2007 .

[9]  J. Gardner Patient-centred medicine and the broad clinical gaze: Measuring outcomes in paediatric deep brain stimulation , 2017 .

[10]  Nafees N. Malik Pay-for-performance pricing for a breakthrough heart drug: learnings for cell and gene therapies. , 2016, Regenerative medicine.

[11]  I. Wilkinson The House Of Lords Select Committee for Science and Technology. Their report on complementary and alternative medicine and its implications for reflexology. . . , 2002, Complementary therapies in nursing & midwifery.

[12]  M. Mazzucato The Entrepreneurial State: Debunking Public vs Private Sector Myths (an excerpt) , 2015, Journal of Economic Sociology.

[13]  S. Schwartzman,et al.  The New Production of Knowledge: The Dynamics of Science and Research in Contemporary Societies , 1994 .

[14]  R. V. Schomberg A Vision of Responsible Research and Innovation , 2013 .

[15]  L. Bromham,et al.  Interdisciplinary research has consistently lower funding success , 2016, Nature.

[16]  A. Faulkner,et al.  Are there specific translational challenges in regenerative medicine? Lessons from other fields. , 2015, Regenerative medicine.

[17]  J. Tait,et al.  Regenerative Medicine: Business Models, Venture Capital and the Funding Gap , 2014 .

[18]  Andrew Webster,et al.  Accelerating Innovation in the Creation of Biovalue , 2017, Science, technology & human values.